Abstract: Provided are techniques for identifying and correcting model focus drift during model training. A model is trained using an original dataset with data, and the is classified into clusters. A representation is assigned to each of the clusters. A first visualization dashboard with visualizations is generated, where each visualization represents a first data distribution of an associated cluster using the representation assigned to that cluster. The model is fine-tuned using a fine-tune dataset. A second visualization dashboard is generated by updating each visualization, where each visualization represents a second data distribution of the associated cluster. It is determined that a cluster of the clusters has focus drift based on changes between the first data distribution and the second data distribution. The focus drift is corrected by: adding the data of the cluster to the fine-tune dataset to form a combined dataset and fine-tuning the model using the combined dataset.

Abstract: This invention discloses a medicinal composition includes a non-coding RNA molecule and an antibody targeting a tumor antigen for preventing and/or treating cancer. This invention uses the synergistic combination of a non-coding RNA molecule or its functional variant or homologue, and an antibody targeting a tumor antigen to prevent and/or treat cancer, thereby providing a novel and effective method in preventing and/or treating various cancers.

Abstract: An apparatus for controlling a cylinder by a microfluidic stream includes a microtube, a first laser-driven photoacoustic microfluid pump (LDMP), and a fiber optic element. The microtube includes a fluid and a cylinder. The fiber optic element includes a first end and a second end. The first end is disposed on the first LDMP and the second end is disposed in a first end portion of the microtube. The first LDMP is configured to generate a directional fluidic jet from the fluid and to push the cylinder in a direction away from the second end of the fiber optic element.

Abstract: This invention discloses a medicinal composition includes a non-coding RNA molecule and an antibody targeting a tumor antigen for preventing and/or treating cancer. This invention uses the synergistic combination of a non-coding RNA molecule or its functional variant or homologue, and an antibody targeting a tumor antigen to prevent and/or treat cancer, thereby providing a novel and effective method in preventing and/or treating various cancers.